Canada markets closed

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7099-0.0003 (-0.04%)
At close: 04:00PM EST
0.7100 +0.00 (+0.01%)
After hours: 05:37PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.7102
Open0.7386
Bid0.6801 x 1400
Ask0.7100 x 800
Day's Range0.6929 - 0.7473
52 Week Range0.6929 - 7.5500
Volume221,663
Avg. Volume953,420
Market Cap22.298M
Beta (5Y Monthly)1.82
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateAug. 20, 2015
1y Target EstN/A
All
News
  • GlobeNewswire

    Catalyst Biosciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that members of its executive management team will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, being held November 29-December 2, 2021. The fireside chat will be available on-demand for registered attendees via the Piper Sandler conference site beginning Monday, November 22, 2021 at 10:00 am ET until the end of the conference

  • GlobeNewswire

    Catalyst Biosciences Announces Change in Corporate Strategy

    Reports Third Quarter 2021 Operating & Financial ResultsCompany to discontinue MarzAA development; focus on developing its complement portfolio Management to host a call today at 8:30 am ET SOUTH SAN FRANCISCO, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced a strategic decision to halt the clinical development of MarzAA, report data to date, and seek a buyer for its hemophilia assets. Catalyst plans to focus its resources on its complement the

  • GlobeNewswire

    Catalyst Biosciences Announces CFI Variant Presentations at Two Upcoming Scientific Conferences

    SOUTH SAN FRANCISCO, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Grant Blouse, Ph.D., chief scientific officer, will present at two upcoming scientific conferences, the 5th Complement-based Drug Development Summit, being held October 26-28, 2021, and the American Society for Biochemistry and Molecular Biology’s (ASBMB) Serine Proteases in Pericellular Proteolysis and Signaling Virtual Meeting, being held October 28-30, 2021. Catalyst w